These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5522140)

  • 1. [Characteristics of ICG and BSP elimination through the liver at different dosages].
    Jaross W; Schentke KU; Richter B; Tschöpel L; Renger F
    Z Gesamte Inn Med; 1970 Sep; 25(18):834-40. PubMed ID: 5522140
    [No Abstract]   [Full Text] [Related]  

  • 2. A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.
    Häcki W; Bircher J; Preisig R
    J Lab Clin Med; 1976 Dec; 88(6):1019-31. PubMed ID: 993641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bromosulfan and indocyanine green test in liver-damaged rats].
    Skorka G; Bien E
    Acta Biol Med Ger; 1980; 39(2-3):271-6. PubMed ID: 7424346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different elimination velocity of indocyanine green in liver diseases of various severity].
    Brügmann E
    Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
    [No Abstract]   [Full Text] [Related]  

  • 5. [The BSP purification tests].
    Chevrel B
    Presse Med (1893); 1969 Apr; 77(18):682. PubMed ID: 5790092
    [No Abstract]   [Full Text] [Related]  

  • 6. [The elimination of bromsulphothalein (BSP): a mathematical investigation of the behavior of this substance after intravenous injection of a single dose].
    Valtueña JP; Calvo del Olmo T; De Castro del Poza S
    Acta Hepatogastroenterol (Stuttg); 1972; 19(5):362-73. PubMed ID: 4668531
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of sulfobromophthalein and indocyanine green clearances in the cat.
    Center SA; Bunch SE; Baldwin BH; Hornbuckle WE; Tennant BC
    Am J Vet Res; 1983 Apr; 44(4):727-30. PubMed ID: 6869973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmental analysis of sulfobromophthalein transport in normal patients and patients with hepatic dysfunction.
    Quarfordt SH; Hilderman HL; Valle D; Waddell E
    Gastroenterology; 1971 Feb; 60(2):246-55. PubMed ID: 5549264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Retention of bromsulphalein in the serum during various stages of activity in chronic hepatitis and liver cirrhosis].
    Vido I; Wildhirt E
    Cesk Gastroenterol Vyz; 1968 Oct; 22(7):433-7. PubMed ID: 5703995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Distribution kinetics of 35S-BSP and 131-I-BR in subjects with healthy livers].
    Uthgenannt H; Adlung J; Schoregge J
    Z Gastroenterol; 1973 Jan; 11(1):3-10. PubMed ID: 4803407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic and renal elimation of bromsulphalein in chronic hepatitis, post-inflammatory cirrhosis and obstructive jaundice].
    Babiuch L
    Przegl Epidemiol; 1975; 29(2):159-67. PubMed ID: 1144806
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of sulfobromophthalein and indocyanine green clearances in the dog.
    Center SA; Bunch SE; Baldwin BH; Hornbuckle WE; Tennant BC
    Am J Vet Res; 1983 Apr; 44(4):722-6. PubMed ID: 6869972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathological and clinical significance of hepatocyte (S) accumulation and maximum transport (M+) of BSF in hepatic cirrhosis and in chronic hepatitis: correlations with sinusoidal flow].
    Di Simone A; Gentile S; Riegler G; Coltorti M
    Boll Soc Ital Biol Sper; 1973 Dec; 49(23):1411-4. PubMed ID: 4803108
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of hyperoxia and induced hypoxia on the BSP and ICG clearance].
    Tasson J; Versieck J; Barbier F
    Tijdschr Gastroenterol; 1966; 9(2):190-205. PubMed ID: 5959804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of anabolizing steroids on BSP excretion in healthy subjects and in patients with liver diseases in the second and third stages of childhood].
    D'Avanzo M; Tiberio P; Lupi L
    Pediatria (Napoli); 1968 Mar; 76(1):113-23. PubMed ID: 5738512
    [No Abstract]   [Full Text] [Related]  

  • 16. Discrimination of hepatobiliary diseases by the evaluation of bromsulfophthalein blood kinetics.
    Molino G; Milanese M; Villa A; Cavanna A; Gaidano GP
    J Lab Clin Med; 1978 Mar; 91(3):396-408. PubMed ID: 627746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What does the BSP retention measure? Comparison of BSP-transport maximum, storage capacity and capacity for elimination of galactose].
    Imesch B; Häcki W; Bircher J
    Schweiz Med Wochenschr; 1973 Mar; 103(11):397-403. PubMed ID: 4691799
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparative study of the kinetics of 131I-bromsulphthalein and 125 I-biligrafin (author's transl)].
    Mostbeck A; Peschl L; Sponer D
    Wien Klin Wochenschr; 1976 Oct; 88(19):627-30. PubMed ID: 983071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ADVANTAGES AND DISADVANTAGES OF BROMSULPHALEIN (BSP) RETENTION TESTS].
    TICHY J
    Cesk Gastroenterol Vyz; 1963 Apr; 17():168-74. PubMed ID: 14054844
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic activity of glutathione transferase and bromsulphalein metabolism].
    Serra MA; Caballero A; Aparisi L; Rodrigo JM; Del Olmo JA; Ferrando J; Wassel AH; Reig G; Bixquert M
    Rev Esp Enferm Dig; 1991 Feb; 79(2):112-6. PubMed ID: 2059513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.